Norman AR - Search Results

1

Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer.

Murthy V, Norman AR, Shahidi M, Parker CC, Horwich A, Huddart RA, Bange A, Dearnaley DP. Murthy V, et al. Among authors: norman ar. BJU Int. 2006 Mar;97(3):476-9. doi: 10.1111/j.1464-410X.2006.06013.x. BJU Int. 2006. PMID: 16469011

2

The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation.

Parker C, Warde P, Norman A, Panzarella T, Catton C, Horwich A, Huddart R, Dearnaley D. Parker C, et al. Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):53-8. doi: 10.1016/s0360-3016(03)00821-6. Int J Radiat Oncol Biol Phys. 2004. PMID: 14697420

3

Early outcomes of active surveillance for localized prostate cancer.

Hardie C, Parker C, Norman A, Eeles R, Horwich A, Huddart R, Dearnaley D. Hardie C, et al. BJU Int. 2005 May;95(7):956-60. doi: 10.1111/j.1464-410X.2005.05446.x. BJU Int. 2005. PMID: 15839912

4

Predictors of histological disease progression in untreated, localized prostate cancer.

Venkitaraman R, Norman A, Woode-Amissah R, Fisher C, Dearnaley D, Horwich A, Huddart R, Khoo V, Thompson A, Parker C. Venkitaraman R, et al. J Urol. 2007 Sep;178(3 Pt 1):833-7. doi: 10.1016/j.juro.2007.05.038. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631355

5

Prostate-specific antigen velocity in untreated, localized prostate cancer.

Venkitaraman R, Norman A, Woode-Amissah R, Dearnaley D, Horwich A, Huddart R, Parker C. Venkitaraman R, et al. BJU Int. 2008 Jan;101(2):161-4. doi: 10.1111/j.1464-410X.2007.07175.x. Epub 2007 Sep 10. BJU Int. 2008. PMID: 17850368

6

Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.

Gilbert DC, Norman AR, Nicholl J, Dearnaley DP, Horwich A, Huddart RA. Gilbert DC, et al. Among authors: norman ar. BJU Int. 2006 Jul;98(1):67-9. doi: 10.1111/j.1464-410X.2006.06188.x. BJU Int. 2006. PMID: 16831145

7

Long-term effects of a short course of neoadjuvant luteinizing hormone-releasing hormone analogue and radical radiotherapy on the hormonal profile in patients with localized prostate cancer.

Murthy V, Norman AR, Barbachano Y, Parker CC, Dearnaley DP. Murthy V, et al. Among authors: norman ar. BJU Int. 2007 Jun;99(6):1380-2. doi: 10.1111/j.1464-410X.2007.06843.x. BJU Int. 2007. PMID: 17537213

8

Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.

van As NJ, Norman AR, Thomas K, Khoo VS, Thompson A, Huddart RA, Horwich A, Dearnaley DP, Parker CC. van As NJ, et al. Among authors: norman ar. Eur Urol. 2008 Dec;54(6):1297-305. doi: 10.1016/j.eururo.2008.02.039. Epub 2008 Mar 7. Eur Urol. 2008. PMID: 18342430

9

Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer.

Shahidi M, Norman AR, Gadd J, Huddart RA, Horwich A, Dearnaley DP. Shahidi M, et al. Among authors: norman ar. Clin Oncol (R Coll Radiol). 2001;13(4):291-5. doi: 10.1053/clon.2001.9272. Clin Oncol (R Coll Radiol). 2001. PMID: 11554629

10

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer.

Parker CC, Norman AR, Huddart RA, Horwich A, Dearnaley DP. Parker CC, et al. Among authors: norman ar. Br J Cancer. 2002 Mar 4;86(5):686-91. doi: 10.1038/sj.bjc.6600160. Br J Cancer. 2002. PMID: 11875726 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters